David L. Lucchino - 22 Nov 2023 Form 4 Insider Report for Korro Bio, Inc. (KRRO)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 Nov 2023, 20:48:47 UTC
Prior SEC filing
22 Nov 2023
Next SEC filing
12 Jun 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ David L. Lucchino

Key filing fact

David L. Lucchino filed Form 4 for Korro Bio, Inc. (KRRO) on 27 Nov 2023.

Key facts

  • This page summarizes David L. Lucchino's Form 4 filing for Korro Bio, Inc. (KRRO).
  • 4 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 27 Nov 2023, 20:48.

Change

  • Previous filing in this sequence was filed on 22 Nov 2023.
  • Current net transaction value: -$43,573.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KRRO transaction

Common Stock

Sale

Transaction value
$3,959
Shares
-110
Change %
-0.47%
Price
$35.99*
Shares after
23,196
Date
22 Nov 2023
Ownership
Direct
Footnotes
F1, F2
KRRO transaction

Common Stock

Sale

Transaction value
$8,450
Shares
-230
Change %
-0.99%
Price
$36.74*
Shares after
22,966
Date
22 Nov 2023
Ownership
Direct
Footnotes
F1, F3
KRRO transaction

Common Stock

Sale

Transaction value
$23,322
Shares
-614
Change %
-2.7%
Price
$37.98*
Shares after
22,352
Date
22 Nov 2023
Ownership
Direct
Footnotes
F1, F4
KRRO transaction

Common Stock

Sale

Transaction value
$7,842
Shares
-202
Change %
-0.9%
Price
$38.82*
Shares after
22,150
Date
22 Nov 2023
Ownership
Direct
Footnotes
F1, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance restricted stock units, and does not represent a discretionary trade by the Reporting Person.

Footnote F2

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.26 to $36.06, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.

Footnote F3

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.40 to $37.20, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.

Footnote F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.52 to $38.35, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.

Footnote F5

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.62 to $39.015, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.

SEC remarks

Exhibit 24.1 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .